NuGen Medical Devices (TSXV:NGMD) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NuGen Medical Devices Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NuGen Medical Devices Business Description

Other Exchanges NGMDF:USA79O:Germany
Address 18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc. is a Canadian medical device company focused on needle-free injection technology. Its lead product, the InsuJet, is a needle-free injection device designed for the subcutaneous delivery of insulin and other injectable medications, offering an alternative to conventional needle-and-syringe delivery. The company develops, manufactures, and commercializes these devices along with related consumables, such as disposable nozzle assemblies, which generate recurring revenue as users replace components with each injection. NuGen targets patients requiring frequent injections, particularly those with diabetes, as well as healthcare providers and distributors. The company sells its products internationally, with revenue historically derived from markets in Europe and Asia, and it also pursues regulatory clearances and distribution partnerships to expand into additional regions. Its business model combines device sales with ongoing consumable purchases.